Cutera, Inc. (CUTR)
NASDAQ: CUTR · IEX Real-Time Price · USD
1.590
+0.040 (2.58%)
At close: Jul 19, 2024, 4:00 PM
1.650
+0.060 (3.77%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
Cutera Revenue
Cutera had revenue of $196.64M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $38.79M. In the year 2023, Cutera had annual revenue of $212.37M.
Revenue (ttm)
$196.64M
Revenue Growth
-21.00%
P/S Ratio
0.16
Revenue / Employee
$457,293
Employees
430
Market Cap
31.96M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 212.37M | -40.03M | -15.86% |
Dec 31, 2022 | 252.40M | 21.13M | 9.14% |
Dec 31, 2021 | 231.27M | 83.59M | 56.60% |
Dec 31, 2020 | 147.68M | -34.03M | -18.73% |
Dec 31, 2019 | 181.71M | 18.99M | 11.67% |
Dec 31, 2018 | 162.72M | 11.23M | 7.41% |
Dec 31, 2017 | 151.49M | 33.44M | 28.32% |
Dec 31, 2016 | 118.06M | 23.30M | 24.58% |
Dec 31, 2015 | 94.76M | 16.62M | 21.27% |
Dec 31, 2014 | 78.14M | 3.54M | 4.75% |
Dec 31, 2013 | 74.59M | -2.68M | -3.47% |
Dec 31, 2012 | 77.28M | 16.99M | 28.18% |
Dec 31, 2011 | 60.29M | 7.02M | 13.17% |
Dec 31, 2010 | 53.27M | -408.00K | -0.76% |
Dec 31, 2009 | 53.68M | -29.70M | -35.62% |
Dec 31, 2008 | 83.38M | -18.35M | -18.04% |
Dec 31, 2007 | 101.73M | 1.03M | 1.03% |
Dec 31, 2006 | 100.69M | 25.07M | 33.16% |
Dec 31, 2005 | 75.62M | 22.98M | 43.65% |
Dec 31, 2004 | 52.64M | 13.55M | 34.67% |
Dec 31, 2003 | 39.09M | 10.76M | 37.99% |
Dec 31, 2002 | 28.33M | 9.00M | 46.56% |
Dec 31, 2001 | 19.33M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
IRIDEX | 49.92M |
Equillium | 37.89M |
ImmuCell | 21.28M |
ReWalk Robotics | 17.91M |
Longeveron | 978.00K |
VYNE Therapeutics | 423.00K |
CUTR News
- 5 weeks ago - Cutera® Announces New Survey Data During Acne Awareness Month - Business Wire
- 5 weeks ago - Cutera® Appoints Jeryl L. Hilleman to Board of Directors - Business Wire
- 6 weeks ago - Cutera® Announces AviClear® Investor Webinar - Business Wire
- 7 weeks ago - Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Business Wire
- 2 months ago - Cutera, Inc. Investor Alert (NASDAQ: CUTR): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors - PRNewsWire
- 2 months ago - Cutera Announces First Quarter 2024 Financial Results - Business Wire
- 3 months ago - Cutera to Announce First Quarter Results on May 9, 2024 - Business Wire
- 3 months ago - Cutera® Announces the North America Launch of xeo®+ - Business Wire